Hungary’s Egis Pharmaceuticals has bolstered its global consumer healthcare offering by snapping up the Sinuforte OTC nasal spray from Spain’s Hartington for an undisclosed sum.
Under the terms of the deal, Egis has gained from Hartington “all rights relating to” Sinuforte – marketed as Nasodren...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?